NLS Collaboration

A new strategic collaboration between life science clusters from Northern Europe and the UK’s National Institute for Health and Care Research (NIHR) is set to open new pathways for companies to engage with the UK’s healthcare and research ecosystem.

Alvotech and Dr. Reddy’s Laboratories have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets.

With the agreement, the Novo Nordisk Foundation expands its existing collaboration with WHO, committing to a granting frame of up to DKK 380 million over the next four years.

The collaboration expands upon ContextVision’s ongoing Data Quality initiative to develop AI-powered, organ-specific imaging solutions that enable MASLD screening and physiological quantification. 

Cinclus Pharma has established a strategic alliance and licensing agreement with Zentiva for the commercialization and manufacturing of its lead asset, linaprazan glurate, in Europe.

Europe ranks highly when it comes to life science know-how and knowledge, but the region is falling behind when it comes to R&D and turning science into real-world solutions. Complex regulations, a fragmented market, scattered funding, and the potential US market tariffs are just some of the challenges ahead.